Controlled Substances: 2014 Established Aggregate Production Quotas for 10 Temporarily Controlled Synthetic Cathinones, 32573-32574 [2014-13082]
Download as PDF
Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices
Supplemental Official Outer
Continental Shelf Block Diagrams in
the Gulf of Mexico, All Located Within
Official Protraction Diagram NG15–09
(Amery Terrace)
Diagrams Revised/Date/Block Numbers
Article IV ‘‘Area’’ Limit Blocks (Total
of 30)—July 1, 2013: 235, 236, 237, 238,
273, 274, 275, 276, 277, 278, 279, 280,
281, 309, 310, 311, 312, 313, 314, 315,
316, 317, 318, 319, 320, 355, 356, 357,
358, 359
SUPPLEMENTARY INFORMATION: Copies of
the revised OPDs and SOBDs are
available for download in .pdf format
from https://www.boem.gov/Oil-and-GasEnergy-Program/Mapping-and-Data/
Maps-And-Spatial-Data.aspx.
FOR FURTHER INFORMATION CONTACT:
Douglas Vandegraft, Chief, Mapping and
Boundary Branch at (703) 787–1312 or
via email at Doug.Vandegraft@
boem.gov.
Dated: May 20, 2014.
Walter D. Cruickshank,
Acting Director, Bureau of Ocean Energy
Management.
[FR Doc. 2014–13001 Filed 6–4–14; 8:45 am]
BILLING CODE 4310–MR–P
DEPARTMENT OF JUSTICE
rmajette on DSK2TPTVN1PROD with NOTICES
Notice of Lodging of Settlement
Agreement Under the Clean Air Act
Notice is hereby given that on May 29,
2014, a proposed consent decree in
United States v. Landfill Technologies
of Arecibo Corp., et al., No. 3:14–cv–
01438, was lodged with the United
States District Court of the District of
Puerto Rico. The United States filed this
action on the same day that the consent
decree was lodged with the Court. The
complaint alleges that defendants
Landfill Technologies of Arecibo Corp.,
the Municipality of Arecibo, and the
Puerto Rico Land Authority violated the
Clean Air Act by failing to timely install
a gas collection and control system at
the municipal solid waste landfill
located in Arecibo, Puerto Rico.
The settlement requires that the
defendants operate the landfill’s gas
collection and control system in
compliance with the applicable
regulations, improve landfill operations,
implement a recycling and composting
plan, and pay civil penalties totaling
$350,000. The consent decree resolves
the civil claims of the United States for
the Clean Air Act violations alleged in
the complaint through the date of
lodging of the consent decree.
The publication of this notice opens
a period for public comment on the
VerDate Mar<15>2010
14:59 Jun 04, 2014
Jkt 232001
consent decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. Landfill Technologies
of Arecibo Corp., D.J. Ref. No. 90–5–2–
1–09629. All comments must be
submitted no later than 30 days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcommentees.enrd@usdoj.gov.
Assistant Attorney General,
U.S. DOJ B ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
During the public comment period,
the consent decree may be examined
and downloaded at this Justice
Department Web site: https://
www.usdoj.gov/enrd/
Consent_Decrees.html. We will provide
a paper copy of the consent decree upon
written request and payment of
reproduction costs. Please mail your
request and payment to: Consent Decree
Library, U.S. DOJ B ENRD, P.O. Box
7611, Washington, DC 20044–7611.
Please enclose a check or money order
for $12.00 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2014–13047 Filed 6–4–14; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–391]
Controlled Substances: 2014
Established Aggregate Production
Quotas for 10 Temporarily Controlled
Synthetic Cathinones
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice.
AGENCY:
This notice establishes the
initial 2014 aggregate production quotas
for 10 temporarily controlled synthetic
cathinones: 4-methyl-N-ethylcathinone
(4–MEC); 4-methyl-apyrrolidinopropiophenone (4-MePPP);
alpha-pyrrolidinopentiophenone (aPVP); 1-(1,3-benzodioxol-5-yl)-2(methylamino)butan-1-one (butylone);
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
32573
2-(methylamino)-1-phenylpentan-1-one
(pentedrone); 1-(1,3-benzodioxol-5-yl)2-(methylamino)pentan-1-one
(pentylone); 4-fluoro-Nmethylcathinone (4–FMC); 3-fluoro-Nmethylcathinone (3–FMC);
naphthylpyrovalerone (naphyrone); and
alpha-pyrrolidinobutiophenone (a-PBP).
DATES: Effective June 5, 2014.
FOR FURTHER INFORMATION CONTACT:
Ruth A. Carter, Office of Diversion
Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152, Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION:
Background
Section 306 of the Controlled
Substances Act (CSA) (21 U.S.C. 826)
requires the Attorney General to
establish aggregate production quotas
for each basic class of controlled
substance listed in schedules I and II
and for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine. The Attorney
General has delegated this authority to
the Administrator of the DEA, 28 CFR
0.100, who in turn has redelegated that
authority to the Deputy Administrator of
the DEA, 28 CFR part 0, subpart R, App.
On March 7, 2014, the DEA published
in the Federal Register a final order to
temporarily place 10 synthetic
cathinones, 4-methyl-N-ethylcathinone
(4–MEC); 4-methyl-apyrrolidinopropiophenone (4-MePPP);
alpha-pyrrolidinopentiophenone (aPVP); 1-(1,3-benzodioxol-5-yl)-2(methylamino)butan-1-one (butylone);
2-(methylamino)-1-phenylpentan-1-one
(pentedrone); 1-(1,3-benzodioxol-5-yl)2-(methylamino)pentan-1-one
(pentylone); 4-fluoro-Nmethylcathinone (4–FMC); 3-fluoro-Nmethylcathinone (3–FMC);
naphthylpyrovalerone (naphyrone); and
alpha-pyrrolidinobutiophenone (a-PBP),
into schedule I of the CSA (79 FR
12938), making all regulations
pertaining to schedule I controlled
substances applicable to the
manufacture of 4–MEC, 4-MePPP, aPVP, butylone, pentedrone, pentylone,
4–FMC, 3–FMC, naphyrone, and a-PBP,
including the requirement to obtain a
manufacturing quota pursuant to 21
CFR part 1303.
The 2014 aggregate production quotas
for 4–MEC, 4-MePPP, a-PVP, butylone,
pentedrone, pentylone, 4–FMC, 3–FMC,
naphyrone, and a-PBP represent those
quantities that may be manufactured in
the United States in 2014 to provide for
the estimated scientific, research, and
industrial needs of the United States,
lawful export requirements, and the
E:\FR\FM\05JNN1.SGM
05JNN1
32574
Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices
establishment and maintenance of
reserve stocks.
On April 1, 2014, the DEA published
a notice titled, ‘‘Controlled Substances:
2014 Proposed Aggregate Production
Quota for 10 Temporarily Controlled
Synthetic Cathinones’’ in the Federal
Register (79 FR 18316). That notice
proposed the 2014 aggregate production
quotas for 4–MEC, 4-MePPP, a-PVP,
butylone, pentedrone, pentylone, 4–
FMC, 3–FMC, naphyrone, and a-PBP.
Interested persons were invited to
comment on or object to the proposed
aggregate production quotas for 4–MEC,
4-MePPP, a-PVP, butylone, pentedrone,
pentylone, 4–FMC, 3–FMC, naphyrone,
and a-PBP on or before May 1, 2014. No
comments were received.
Analysis for 2014 Established Aggregate
Production Quotas
In determining the 2014 aggregate
production quotas for 4-methyl-Nethylcathinone (4–MEC); 4-methyl-apyrrolidinopropiophenone (4-MePPP);
alpha-pyrrolidinopentiophenone (aPVP); 1-(1,3-benzodioxol-5-yl)-2(methylamino)butan-1-one (butylone);
2-(methylamino)-1-phenylpentan-1-one
(pentedrone); 1-(1,3-benzodioxol-5-yl)2-(methylamino)pentan-1-one
(pentylone); 4-fluoro-Nmethylcathinone (4–FMC); 3-fluoro-Nmethylcathinone (3–FMC);
naphthylpyrovalerone (naphyrone); and
alpha-pyrrolidinobutiophenone (a-PBP),
the DEA has taken into consideration
the factors set forth at 21 CFR 1303.11,
pursuant to 21 U.S.C. 826(a), and other
relevant factors, including 2014 export
requirements, industrial use,
applications for quotas, as well as
information on research and product
development requirements.
Pursuant to 21 U.S.C. 826 and in
accordance with 21 CFR 1303.11, the
Deputy Administrator hereby
establishes the 2014 aggregate
production quotas for 4–MEC, 4-MePPP,
a-PVP, butylone, pentedrone,
pentylone, 4–FMC, 3–FMC, naphyrone,
and a-PBP, expressed in grams of
anhydrous acid or base, as follows:
Established 2014
quota
Basic class—schedule I
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone) ...............................................................................................
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone) ...........................................................................................
2-(methylamino)-1-phenylpentan-1-one (pentedrone) .................................................................................................................
3-fluoro-N-methylcathinone (3–FMC) ..........................................................................................................................................
4-fluoro-N-methylcathinone (4–FMC) ..........................................................................................................................................
4-methyl-N-ethylcathinone (4–MEC) ...........................................................................................................................................
4-methyl-a-pyrrolidinopropiophenone (4-MePPP) .......................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ......................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ....................................................................................................................................
naphthylpyrovalerone (naphyrone) ..............................................................................................................................................
In accordance with 21 CFR 1303.13,
upon consideration of the relevant
factors, the Deputy Administrator may
adjust the 2014 aggregate production
quotas for 4–MEC, 4-MePPP, a-PVP,
butylone, pentedrone, pentylone, 4–
FMC, 3–FMC, naphyrone, and a-PBP as
needed.
Dated: May 30, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014–13082 Filed 6–4–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (OJJDP) Docket No. 1660]
Hearing of the Advisory Committee of
the Attorney General’s Task Force on
American Indian/Alaska Native
Children Exposed to Violence
Office of Juvenile Justice and
Delinquency Prevention (OJJDP),
Department of Justice.
ACTION: Notice of hearing.
rmajette on DSK2TPTVN1PROD with NOTICES
AGENCY:
This is an announcement of
the fourth hearing of the Advisory
Committee of the Attorney General’s
Task Force on American Indian/Alaska
Native Children Exposed to Violence
SUMMARY:
VerDate Mar<15>2010
14:59 Jun 04, 2014
Jkt 232001
(hereafter referred to as the AIAN
Advisory Committee). The AIAN
Advisory Committee is chartered to
provide the Attorney General with
valuable advice in the areas of American
Indian/Alaska Native children’s
exposure to violence for the purpose of
addressing the epidemic levels of
exposure to violence faced by tribal
youth. Based on the testimony at four
public hearings, on comprehensive
research, and on extensive input from
experts, advocates, impacted families
and tribal communities nationwide, the
AIAN Advisory Committee will issue a
final report to the Attorney General
presenting its findings and
comprehensive policy recommendations
in the fall of 2014.
DATES: This fourth hearing will take
place in Anchorage, Alaska on
Wednesday, June 11, 2014, from 1:00
p.m. to 6:30 p.m.; and Thursday, June
12, 2014, from 8:30 a.m. to 6:30 p.m. A
post-hearing debrief session will take
place in Anchorage, Alaska on Friday,
June 13, 2014, from 8:30 a.m. to 5:00
p.m. It is anticipated that a public
listening session prior to the hearing
itself will take place in Bethel, Alaska
on Monday, June 9, 2014, from 1:30
p.m. to 5:30 p.m.
ADDRESSES: The Anchorage, Alaska
hearing and post-hearing debrief session
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
15
15
15
15
15
15
15
15
15
15
g
g
g
g
g
g
g
g
g
g
will both take place at the Sheraton
Anchorage Hotel, 401 East 6th Avenue,
Anchorage, Alaska 99501. Phone: (907)
276–8700. The hearing will take place
in the Howard Rock Ballroom at the
Sheraton Anchorage Hotel. The debrief
session will take place in the Susitna
Room at the Sheraton Anchorage Hotel.
The public listening session in Bethel,
Alaska will take place at the Yupiit
Piciryarait Cultural Center, 420 Chief
Eddie Hoffman Highway, Bethel, AK
99559. Phone: (907) 543–4500.
FOR FURTHER INFORMATION CONTACT: Jim
Antal, AIAN Advisory Committee
Designated Federal Officer (DFO) and
Deputy Associate Administrator, Youth
Development, Prevention and Safety
Division, Office of Juvenile Justice &
Delinquency Prevention, Office of
Justice Programs, 810 7th Street NW.,
Washington, DC 20531. Phone: (202)
514–1289 [note: this is not a toll-free
number]; email: james.antal@usdoj.gov.
SUPPLEMENTARY INFORMATION: This
Anchorage, Alaska hearing and the
anticipated Bethel, Alaska listening
session are both being convened to
provide information to the AIAN
Advisory Committee about the issue of
American Indian/Alaska Native
children’s exposure to violence. The
focus for this fourth hearing will be on
Alaska Native children exposed to
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 79, Number 108 (Thursday, June 5, 2014)]
[Notices]
[Pages 32573-32574]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13082]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-391]
Controlled Substances: 2014 Established Aggregate Production
Quotas for 10 Temporarily Controlled Synthetic Cathinones
AGENCY: Drug Enforcement Administration (DEA), Department of Justice.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice establishes the initial 2014 aggregate production
quotas for 10 temporarily controlled synthetic cathinones: 4-methyl-N-
ethylcathinone (4-MEC); 4-methyl-[alpha]-pyrrolidinopropiophenone (4-
MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-
benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone); 2-
(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-
yl)-2-(methylamino)pentan-1-one (pentylone); 4-fluoro-N-methylcathinone
(4-FMC); 3-fluoro-N-methylcathinone (3-FMC); naphthylpyrovalerone
(naphyrone); and alpha-pyrrolidinobutiophenone ([alpha]-PBP).
DATES: Effective June 5, 2014.
FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Office of Diversion
Control, Drug Enforcement Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-
6812.
SUPPLEMENTARY INFORMATION:
Background
Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826)
requires the Attorney General to establish aggregate production quotas
for each basic class of controlled substance listed in schedules I and
II and for the list I chemicals ephedrine, pseudoephedrine, and
phenylpropanolamine. The Attorney General has delegated this authority
to the Administrator of the DEA, 28 CFR 0.100, who in turn has
redelegated that authority to the Deputy Administrator of the DEA, 28
CFR part 0, subpart R, App.
On March 7, 2014, the DEA published in the Federal Register a final
order to temporarily place 10 synthetic cathinones, 4-methyl-N-
ethylcathinone (4-MEC); 4-methyl-[alpha]-pyrrolidinopropiophenone (4-
MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-
benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone); 2-
(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-
yl)-2-(methylamino)pentan-1-one (pentylone); 4-fluoro-N-methylcathinone
(4-FMC); 3-fluoro-N-methylcathinone (3-FMC); naphthylpyrovalerone
(naphyrone); and alpha-pyrrolidinobutiophenone ([alpha]-PBP), into
schedule I of the CSA (79 FR 12938), making all regulations pertaining
to schedule I controlled substances applicable to the manufacture of 4-
MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-
FMC, naphyrone, and [alpha]-PBP, including the requirement to obtain a
manufacturing quota pursuant to 21 CFR part 1303.
The 2014 aggregate production quotas for 4-MEC, 4-MePPP, [alpha]-
PVP, butylone, pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, and
[alpha]-PBP represent those quantities that may be manufactured in the
United States in 2014 to provide for the estimated scientific,
research, and industrial needs of the United States, lawful export
requirements, and the
[[Page 32574]]
establishment and maintenance of reserve stocks.
On April 1, 2014, the DEA published a notice titled, ``Controlled
Substances: 2014 Proposed Aggregate Production Quota for 10 Temporarily
Controlled Synthetic Cathinones'' in the Federal Register (79 FR
18316). That notice proposed the 2014 aggregate production quotas for
4-MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-
FMC, naphyrone, and [alpha]-PBP. Interested persons were invited to
comment on or object to the proposed aggregate production quotas for 4-
MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-
FMC, naphyrone, and [alpha]-PBP on or before May 1, 2014. No comments
were received.
Analysis for 2014 Established Aggregate Production Quotas
In determining the 2014 aggregate production quotas for 4-methyl-N-
ethylcathinone (4-MEC); 4-methyl-[alpha]-pyrrolidinopropiophenone (4-
MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-
benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone); 2-
(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-
yl)-2-(methylamino)pentan-1-one (pentylone); 4-fluoro-N-methylcathinone
(4-FMC); 3-fluoro-N-methylcathinone (3-FMC); naphthylpyrovalerone
(naphyrone); and alpha-pyrrolidinobutiophenone ([alpha]-PBP), the DEA
has taken into consideration the factors set forth at 21 CFR 1303.11,
pursuant to 21 U.S.C. 826(a), and other relevant factors, including
2014 export requirements, industrial use, applications for quotas, as
well as information on research and product development requirements.
Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11,
the Deputy Administrator hereby establishes the 2014 aggregate
production quotas for 4-MEC, 4-MePPP, [alpha]-PVP, butylone,
pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, and [alpha]-PBP,
expressed in grams of anhydrous acid or base, as follows:
------------------------------------------------------------------------
Established 2014
Basic class--schedule I quota
------------------------------------------------------------------------
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one 15 g
(butylone).........................................
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one 15 g
(pentylone)........................................
2-(methylamino)-1-phenylpentan-1-one (pentedrone)... 15 g
3-fluoro-N-methylcathinone (3-FMC).................. 15 g
4-fluoro-N-methylcathinone (4-FMC).................. 15 g
4-methyl-N-ethylcathinone (4-MEC)................... 15 g
4-methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP). 15 g
alpha-pyrrolidinobutiophenone ([alpha]-PBP)......... 15 g
alpha-pyrrolidinopentiophenone ([alpha]-PVP)........ 15 g
naphthylpyrovalerone (naphyrone).................... 15 g
------------------------------------------------------------------------
In accordance with 21 CFR 1303.13, upon consideration of the
relevant factors, the Deputy Administrator may adjust the 2014
aggregate production quotas for 4-MEC, 4-MePPP, [alpha]-PVP, butylone,
pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, and [alpha]-PBP as
needed.
Dated: May 30, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014-13082 Filed 6-4-14; 8:45 am]
BILLING CODE 4410-09-P